Background: Neuro-cognitive deficits are a core feature of psychosis. In the clinical high risk stages of psychosis, neuro-cognitive deficits qualitatively affect the same functions while being quantitatively less marked compared to those in full-blown disorder. Therefore, cognitive impairments are considered to be an important intermediate phenotype for transition to psychosis. Partially overlapping deficits were also reported in depressive disorders, so it is important to identify deficits specifically associated to psychotic symptoms from those common to other conditions. We aimed to identify and differentiate cognitive deficits specifically associated to [i] Differences between ROD and CHR/ROP groups [ii] were detected in: speed of execution (all p≤0.001); sustained attention (p≤0.011); short-term and working memory (p≤0.004); long-term memory (p≤0.001); semantic verbal fluency (p=0.024); emotion recognition (p=0.005); and estimation of adaptive salience (p=0.021). When compared with ROP, CHR [iii] performed significantly better in the same domains that differentiated ROD from CHR/ROP, with the important exception of long-term memory measures (p≥0.094). Discussion: These results are consistent with the expectations drawn from previous literature on the neuropsychological impairments in psychotic disorders and CHR participants. Furthermore, PCB showed to be useful in [i] psychopathology in general, [ii] differentiating between recent-onset depression and psychotic symptoms, and [iii] between threshold and subthreshold psychotic symptoms. Interestingly, long-term memory deficits contributed more in differentiating psychotic symptoms from other psychopathological entities (ROD vs CHR/ROP comparison) than along the spectrum of attenuated psychotic symptoms, resulting in full clinical picture of psychosis (CHR vs ROP). Finally, salience attribution difficulties were confirmed to be associated with (sub-)threshold psychotic symptoms, more than to general psychopathology.
T86. COGNITIVE SUBTYPES IN FIRST-EPISODE PSYCHOSIS: AN EMPIRICAL LONGITUDINAL STUDY OF RELATIONSHIP TO COGNITIVE, SYMPTOM AND FUNCTIONAL OUTCOMES
Background: Variable outcomes following a first-episode of psychosis are partly attributable to heterogeneity in cognitive functioning. Previous work in first episode psychosis has identified clinically meaningful cognitive subtypes based on pre-specified differences in estimated premorbid and current cognitive functioning. We used an empirical clustering technique to examine whether these cognitive profiles can be replicated with an unbiased method, their relationship with clinical, cognitive and global functioning at psychosis onset as well as their stability over time.
Methods: Patients attending NHS early intervention services following a first episode of psychosis were recruited to a double-blind clinical trial of minocycline for negative symptoms of psychosis (BeneMin) which found no treatment effect. Participants were assessed on clinical, cognitive and global functioning at baseline (n=169) and 12-month follow-up (n=107). K-means analysis was used to empirically cluster participants on the basis of estimated premorbid IQ (WTAR), and baseline cognitive functioning (derived from 4 sub-tests of the WAIS IV, verbal fluency (COWAT) and verbal learning scores (AVLT)). Clinical and global functioning was assessed using the Positive and Negative Syndrome Scale (PANSS), Calgary Depression Scale (CDS) and Global Assessment of Functioning (GAF).
Results: K-means cluster analysis revealed three cognitive subgroups: 28% showing preserved premorbid and current IQ (PIQ); 29% displaying compromised premorbid and current IQ (CIQ); and 43% with normal premorbid but deteriorated current IQ (DIQ). There were no significant differences between groups in age, gender, CDS, cannabis use or olanzapine equivalent antipsychotic dose. The PIQ group performed significantly better than the DIQ group on all baseline cognitive measures, who performed significantly better than the CIQ group. At baseline, there were significant differences in GAF scores (F(2,168) = 4.267, p=0.016; PIQ >DIQ, LIQ). At 12-months, all three groups had improved over time on cognitive function with no group x time interactions except verbal fluency (F(2, 97) = 5.204,p=0.007) where only the DIQ group improved. All groups improved on positive and total symptom scores but only the PIQ and DIQ groups significantly improved on negative and general symptom scales. There was no significant change in GAF score in any of the groups over time. At follow-up there were significant differences between groups in negative syndrome scores (F(2, 104) = 8.720, p=0.004: LIQ > PIQ, DIQ) and global functioning (F(2,101) = 5.880 p=0.004; PIQ > DIQ, LIQ). Discussion: Using an unbiased method to define cognitive subgroups at first episode, we confirmed in a new sample, previous findings which used prespecified criteria. A large subgroup showed evidence of a decline in IQ at psychosis onset and 12-months later this subgroup had neither continued to deteriorate nor returned to premorbid levels of cognition. Patients with preserved normal and compromised cognitive function at psychosis onset showed no deterioration over 12 months. The cognitive sub-groupings were clinically meaningful. The preserved group showed better general function which persisted over 12 months. General functional outcome in the IQ decline group was as poor as the compromised group and the compromised group had more persistent negative symptoms. 
T87. TOWARD DEVELOPING CLINICAL CUTOFF VALUES FOR THE BECK COGNITIVE INSIGHT SCALE

